Evommune, Inc.
EVMNNYSECIK 2044725HealthcareFiscal year ends Dec 31
Reports and events: 27 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0112:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-409865 |
| 2026-09-2320:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-399378 |
| 2026-09-1512:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-391390 |
| 2026-09-0922:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385430 |
| 2026-08-0620:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-337984 |
| 2026-08-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337964 |
| 2026-07-3012:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324972 |
| 2026-06-2912:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286918 |
| 2026-06-0220:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-253482 |
| 2026-05-0720:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211963 |
| 2026-05-0720:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-211934 |
| 2026-04-2120:05 ET | DEF 14A | Proxy statementPeriod 2026-04-21 | 0001193125-26-166747 |
| 2026-04-1720:05 ET | S-1 | Registration statement | 0001193125-26-161516 |
| 2026-04-1320:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-152864 |
| 2026-03-0521:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-093932 |
| 2026-03-0521:05 ET | 8-K | 2.02 Results of operations | 0001193125-26-093920 |
| 2026-02-1921:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-059504 |
| 2026-02-1700:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000063 |
| 2026-02-1313:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-049888 |
| 2026-02-1013:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-043771 |
| 2025-12-1121:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-315972 |
| 2025-12-1121:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-315918 |
| 2025-11-1721:44 ET | SCHEDULE 13D | Ownership report, active investor | 0001346824-25-000063 |
| 2025-11-1421:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-283141 |
| 2025-11-0721:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-272282 |
| 2025-10-1720:06 ET | S-1/A | Registration statement, amended | 0001193125-25-242492 |
| 2025-10-0918:18 ET | S-1 | Registration statement | 0001193125-25-235673 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.